Clinical Trials

Our physicians participate in clinical trials to incorporate state-of-the-art patient care, while carefully evaluating how best to apply the most recent developments in cancer therapy.

NorthMain physicians participate in many research cooperative groups at the national, regional and local levels: RTOG (Radiation Therapy Oncology Group), ECOG (Eastern Cooperative Oncology Group), CALGB (Cancer and Leukemia Group B), GOG (Gynecologic Oncology Group), NSABP (National Surgical Adjuvant Breast and Bowel Project), and BrUOG (Brown University Oncology Group).

Some of the clinical trials require the use of complex technologies such as Intensity Modulated Radiotherapy (IMRT) or surgically placed small radiation sources directly into the tumor. The National Cancer Institute (NCI) oversees these clinical trials and requires its research partners to demonstrate the accuracy of the treatments. NorthMain Radiation Oncology is among major academic sites in the US to be credentialed by the NCI for IMRT, Mammosite© and permanent prostate seed implants. Our patients and their families can be assured of the highest standards of care.

Several of our physicians are members of the Executive Committee of BrUOG and participate in specific disease site protocol development. Dr. Kathy Radie-Keane Chairs the BrUOG Radiation Oncology Committee.

These activities are an integral part of providing our patients with the opportunity to receive the best cancer treatment available.

Next